Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Giovanni Lavorgna"'
Autor:
Giovanni Lavorgna, Giulio Cavalli, Lorenzo Dagna, Silvia Gregori, Alessandro Larcher, Giovanni Landoni, Fabio Ciceri, Francesco Montorsi, Andrea Salonia
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract As for all newly-emergent pathogens, SARS-CoV-2 presents with a relative paucity of clinical information and experimental models, a situation hampering both the development of new effective treatments and the prediction of future outbreaks.
Externí odkaz:
https://doaj.org/article/c7ea18b3b3a340c1a5a5c94cae73ab75
Autor:
Giovanni Lavorgna, Anna Sofia Tascini, Alessandro Bertini, Francesco Lanzaro, Francesco Montorsi, Massimo Alfano, Andrea Salonia
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Mechanisms underlying severe male infertility are still largely elusive. However, recently, a single-cell transcription study by our group identified several differentially expressed coding genes in all the somatic cell types in testes of patients wi
Externí odkaz:
https://doaj.org/article/6c835752db8142b48eef70de0e3c8995
Autor:
Francesco Pellegrino, Arianna Coghi, Giovanni Lavorgna, Walter Cazzaniga, Edoardo Guazzoni, Irene Locatelli, Isabella Villa, Simona Bolamperti, Nadia Finocchio, Massimo Alfano, Roberta Lucianò, Alberto Briganti, Francesco Montorsi, Andrea Salonia, Ilaria Cavarretta
Publikováno v:
Translational Oncology, Vol 14, Iss 11, Pp 101211- (2021)
Aim: Since its discovery Prostate Specific Antigen (PSA), also referred to as kallikrein-3 (KLK3), has been used as standard circulating biomarker for prostate cancer (PCa). However, its specificity remains not adequate and its mechanism of action st
Externí odkaz:
https://doaj.org/article/2bbe99ecfaa54d1fb63f2b47de5c61e5
Autor:
Giovanni Lavorgna, Fulvio Chiacchiera, Alberto Briganti, Francesco Montorsi, Diego Pasini, Andrea Salonia
Publikováno v:
Genomics Data, Vol 3, Iss C, Pp 4-5 (2015)
We recently identified the long non-coding RNA (ncRNA) TRPM2-AS as a key regulator of survival in prostate cancer [1]. This essential role, coupled to the TRPM2-AS low-expression levels in healthy tissues, makes this ncRNA a suitable therapeutic targ
Externí odkaz:
https://doaj.org/article/488063789c044291b25d8597646e6e43
Autor:
Pär G Engström, Harukazu Suzuki, Noriko Ninomiya, Altuna Akalin, Luca Sessa, Giovanni Lavorgna, Alessandro Brozzi, Lucilla Luzi, Sin Lam Tan, Liang Yang, Galih Kunarso, Edwin Lian-Chong Ng, Serge Batalov, Claes Wahlestedt, Chikatoshi Kai, Jun Kawai, Piero Carninci, Yoshihide Hayashizaki, Christine Wells, Vladimir B Bajic, Valerio Orlando, James F Reid, Boris Lenhard, Leonard Lipovich
Publikováno v:
PLoS Genetics, Vol 2, Iss 4, p e47 (2006)
Mammalian genomes harbor a larger than expected number of complex loci, in which multiple genes are coupled by shared transcribed regions in antisense orientation and/or by bidirectional core promoters. To determine the incidence, functional signific
Externí odkaz:
https://doaj.org/article/b98bcc6724cf40cdabf42933acd063ca
Autor:
Ilaria T. Cavarretta, Nadia Finocchio, Irene Locatelli, Francesco Montorsi, Alberto Briganti, Simona Bolamperti, Edoardo Guazzoni, Francesco Pellegrino, Giovanni Lavorgna, Andrea Salonia, Arianna Coghi, Roberta Lucianò, Walter Cazzaniga, Isabella Villa, Massimo Alfano
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 11, Pp 101211-(2021)
Translational Oncology, Vol 14, Iss 11, Pp 101211-(2021)
Highlights • Prostate specific antigen is the standard circulating biomarker for prostate cancer. • We provide novel evidence that collagen 1 is an additional substrate for PSA. • PSA hampers first steps of cancer invasion. • Tissue-related P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42eaf2d688eec21c9234c02bcdb8710
https://pubmed.ncbi.nlm.nih.gov/34455373
https://pubmed.ncbi.nlm.nih.gov/34455373
Autor:
Edoardo Pozzi, Ilaria T. Cavarretta, Tiziana Tempio, Giovanni Lavorgna, Irene Locatelli, Francesco Montorsi, Agostino Mattei, Andrea Salonia, Roberto Sitia, Julian Cornelius, Tiziana Anelli
Publikováno v:
Transl Androl Urol
Background Therapies available for late stage prostate cancer (PCa) patients are limited and mostly palliative. The necessary development of unexplored therapeutic options relies on a deeper knowledge of molecular mechanisms leading to cancer progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f9061a3fc44ad619ef1c90369d86e9
https://pubmed.ncbi.nlm.nih.gov/33850746
https://pubmed.ncbi.nlm.nih.gov/33850746
Autor:
Lorenzo Dagna, Alessandro Larcher, Giulio Cavalli, Giovanni Lavorgna, Giovanni Landoni, Francesco Montorsi, Silvia Gregori, Fabio Ciceri, Andrea Salonia
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
As for all newly-emergent pathogens, SARS-CoV-2 presents with a relative paucity of clinical information and experimental models, a situation hampering both the development of new effective treatments and the prediction of future outbreaks. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c47d59622fd67bf80d7784759cda7b
Publikováno v:
European Urology. 77:767-768
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf3a7f485edab504902948633f54647
https://doi.org/10.1016/j.eururo.2020.02.027
https://doi.org/10.1016/j.eururo.2020.02.027